Do you have a new upper respiratory tract infection?
Requirements to participate
- Must be at least 18 years old, with individuals 65 years of age or older encouraged to participate.
- Must have recently tested positive for RSV (Respiratory Syncytial Virus).
- Must have a history of congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), or asthma.
- Requires meeting with a study physician to determine full eligibility.
- The study physician will assess if the study is right for you.
- Additional medical and lifestyle factors may be evaluated during the screening process.
Application For Upper Respiratory Tract Infection
A Clinical Trial might Be an Option For you
The purpose of this research study is to see if EDP-938 (an experimental drug) is safe and effective when treating RSV (a common respiratory infection), as compared to treating RSV with a placebo (a pill that has no active medicine in it), by you providing information of your symptoms on a daily basis.
How Long Does this Study last and what will have to do?
If you decide to participate in this study, you will be asked to make a total of 6 visits to the study location over the next 33 days. Your study physician will provide you with the study drug, which could contain either active treatment or placebo, and perform assessments to track your overall health and progress throughout the study.
